<DOC>
	<DOCNO>NCT02956278</DOCNO>
	<brief_summary>Subjects undergo placebo allopurinol phase well understand effect reduce function BCRP Q141K variant allopurinol pharmacokinetics pharmacodynamics .</brief_summary>
	<brief_title>The Effects BCRP Q141K Allopurinol Pharmacokinetics Dynamics</brief_title>
	<detailed_description />
	<mesh_term>Hyperuricemia</mesh_term>
	<mesh_term>Allopurinol</mesh_term>
	<criteria>selfidentified Asian/European ancestry generally healthy approve lab value CBC , HFP , RFP , uric acid Subjects ABCG2 genotype , homozygous , heterozygous homozygous major allele rs2231142 recruit vascular disease renal impairment medications/supplements affect uric acid level pregnant lactate woman prior history allergic reaction allopurinol test positive HLAB*5801 allele risk urinary gastric retention narrowangle glaucoma impair hepatic function evidence anemia evidence diagnosis congestive heart failure smoker subject mutation rs2231142 ABCG2 genotype subject take hormonal contraceptive hormonal medication evidence recreational drug use determine questionnaire</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>allopurinol</keyword>
</DOC>